Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus

While basal insulin remains the most effective antidiabetic agent and substantially reduces the risk of hypoglycemia, few studies have examined the comparative effect of basal insulin in the real-world setting. This study aimed to assess the outcomes of adding basal insulin compared with thiazolidin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chih-Ning, Wang, Chih-Yuan, Lin, Hung-Wei, Chang, Ting-Yu, Lin, Hsu-Ju, Chou, Chiahung, Lin, Fang-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113251/
https://www.ncbi.nlm.nih.gov/pubmed/32238842
http://dx.doi.org/10.1038/s41598-020-62646-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113251/
https://www.ncbi.nlm.nih.gov/pubmed/32238842
http://dx.doi.org/10.1038/s41598-020-62646-z

Ejemplares similares